KLF13 polyclonal antibody

• Background :

  Represses transcription by binding to the BTE site, a GC-rich DNA element, in competition with the activator SP1.

• Structure Composition :

  Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.

• Product Name Alternative :

  KLF13; BTEB3; NSLP1; Krueppel-like factor 13; Basic transcription element-binding protein 3; BTE-binding protein 3; Novel Sp1-like zinc finger transcription factor 1; RANTES factor of late activated T-lymphocytes 1; RFLAT-1; Transcription factor BTEB3; Transcription factor NSLP1

• Swiss Prot :

  Q9Y2Y9

• Reactivity :

  Human, Mouse

• Immunogen :

  The antiserum was produced against synthesized peptide derived from human KLF13 around the non-acetylation site of Lys166. AA range:131-180

• Conjugation :

  Unconjugated

• Applications :

  WB, IHC-P, ELISA

• Dilution :

  WB: 1/500-1/1000 IHC: 1/50-1/100 ELISA: 1/10000

• Purity :

  Affinity Purified

• Modification :

  Unmodified

• Molecular Weight :

  Calculated MW: 31 kDa; Observed MW: 31 kDa

• Storage Conditions :

  Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

• Notes :

  For research use only, not for use in diagnostic procedure.

• Specificity :

  IgG

• Applications Notes :

  Western blot analysis of KLF13 in L929 lysates using KLF13 antibody.

• Host or Source :

  Rabbit

• CAS Number :

  9007-83-4